Company overview
Ultima Genomics provides high-throughput, cost-effective DNA sequencing platforms like the UG 100 and UG200 series for population-scale genomics. They offer solutions for whole genome sequencing at $80 per genome, single-cell sequencing at $0.0048 per cell, oncology, and proteomics applications. Key features include open wafer technology, Solaris 2.0 workflows for improved coverage in complex regions, and capacities exceeding 60,000 30x WGS per year.
Ultima Genomics is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include ultima genomics, dna sequencing, whole genome sequencing, single-cell sequencing, high-throughput genomics.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.ultimagenomics.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- ultima genomics, dna sequencing, whole genome sequencing, single-cell sequencing, high-throughput genomics
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What sequencing platforms does Ultima Genomics offer?
- Ultima Genomics offers the UG 100 Sequencing Platform and the new UG200 Series, including the UG200 Ultra dual-wafer system priced at $1,250,000, supporting up to 60 wafers per week and over 60,000 30x whole genomes per year.
- What are the key applications and focus areas?
- Focus areas include germline whole genome sequencing, oncology, single-cell sequencing, and proteomics, with compatible workflows for 10x Genomics, Parse Biosciences, and BioSkryb Genomics, enabling $80 genomes and $0.0048 per cell.
- What throughput and cost capabilities are available?
- Platforms deliver up to 20B reads per wafer with 10B and 5B configurations, continuous 24/7 operation, and automated queuing for 60 wafers weekly at 150-300 base read lengths, starting at $850,000 for instruments.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
